Clinical trials
Phase 2 Neoplasm Metastasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,013 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 10 |
| 2002 | 20 |
| 2003 | 29 |
| 2004 | 26 |
| 2005 | 45 |
| 2006 | 51 |
| 2007 | 58 |
| 2008 | 31 |
| 2009 | 49 |
| 2010 | 40 |
| 2011 | 47 |
| 2012 | 38 |
| 2013 | 51 |
| 2014 | 46 |
| 2015 | 22 |
| 2016 | 36 |
| 2017 | 35 |
| 2018 | 33 |
| 2019 | 42 |
| 2020 | 38 |
| 2021 | 48 |
| 2022 | 29 |
| 2023 | 29 |
| 2024 | 35 |
| 2025 | 27 |
| 2026 | 51 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 477 |
| Terminated | 183 |
| Unknown status | 99 |
| Recruiting | 88 |
| Active, not recruiting | 65 |
| Withdrawn | 63 |
| Not yet recruiting | 34 |
| Suspended | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 41 |
| National Cancer Institute (NCI) | 29 |
| UNICANCER | 18 |
| Amgen | 16 |
| Memorial Sloan Kettering Cancer Center | 16 |
| H. Lee Moffitt Cancer Center and Research Institute | 14 |
| Eli Lilly and Company | 13 |
| AstraZeneca | 12 |
| Dana-Farber Cancer Institute | 12 |
| Fudan University | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 1,013 |
| Neoplasms | 154 |
| Breast Neoplasms | 150 |
| Colorectal Neoplasms | 126 |
| Recurrence | 83 |
| Carcinoma, Non-Small-Cell Lung | 73 |
| Prostatic Neoplasms | 64 |
| Carcinoma, Renal Cell | 60 |
| Melanoma | 60 |
| Lung Neoplasms | 51 |
Trials
Showing 1 to 25 of 1,013. Each trial links to its page on Pharma Observatory.
913 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.